Er OON denied for missing prior authorization by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for er oon are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Requires Prior Authorization for Extended-Release Opioids

UnitedHealthcare requires prior authorization (PA) for extended-release opioids as part of its opioid management program. PA requirements for this drug class reflect both regulatory guidance and plan-level risk-management policy. A claim denied for "prior authorization required" means coverage was not pre-approved before the prescription was filled, or a PA request was submitted but did not meet UHC's clinical criteria.

## Why This Denial Is Appealable

If the PA was not obtained due to a prescriber or pharmacy administrative gap, a retroactive PA request (where permitted) or an internal appeal arguing medical necessity can still result in coverage. If a PA was submitted and denied, the substantive clinical criteria used to deny it can be challenged on appeal with organized documentation. The plan must evaluate the actual clinical record — not just whether a form was completed.

## Federal Appeal Framework

• Retroactive PA / internal appeal: File within the deadline on your denial notice. If the drug was dispensed and the claim denied, an internal appeal is the immediate path.
• Expedited review: If ongoing therapy is medically urgent, request expedited internal appeal — response required within 72 hours.
• External review (ACA §2719 / ERISA §503): After exhausting internal appeal, file for independent external review within approximately four months of the final denial. The IRO's decision is binding.

## Appeal Process and Timeline

1. Obtain the PA criteria from UHC's published clinical coverage policy for this drug. 2. Confirm with your prescriber's office whether a PA was submitted and, if so, what documentation accompanied it. 3. Identify any gaps between the documentation submitted and the policy criteria; gather the missing chart evidence. 4. Have the prescriber resubmit a PA with complete documentation, or file a formal internal appeal if a PA was already denied. 5. Escalate to external review if the internal appeal fails.

## Documentation to Gather

• Diagnosis documentation: Chart notes, objective findings, functional-impact assessment establishing medical need.
• Prior-treatment history: Non-opioid therapies and immediate-release opioids trialed, with dates and outcomes.
• Prescriber letter of medical necessity: Directly addressing each PA criterion — qualifying diagnosis, prior-therapy requirements, risk-management steps taken.
• Risk-stratification records: Opioid risk assessment, PDMP check, patient agreement — as required by the policy.
• Functional baseline and goals: Documentation of expected functional improvement as the therapeutic goal.

## Criteria-Mapping Structure

Obtain the UHC PA/clinical coverage policy. Copy each criterion into your appeal letter as a numbered list. Under each item, record the specific chart note, date, and provider statement that satisfies it. Where the FDA prescribing label is relevant — for example, to confirm an approved indication — cite and attach the applicable label section. A criterion-by-criterion mapping is the most effective format for both internal reviewers and external IRO reviewers.